Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for selective binding to estrogen receptors alpha/beta relative to GPER/GPR30 and methods of treating disease states and conditions mediated through these receptors

Compounds for selective binding to estrogen receptors alpha/beta relative to GPER/GPR30 and methods of treating disease states and conditions mediated through these receptors

US Patent 12509435 · Granted Dec 30, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2024
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2021
Human GLUT5 specific inhibitors and methods of treatment2020
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2020
Inhibition and treatment of bacterial infections by sex-specific GPER targeting2020
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2019
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2019
Selective inhibitors of EG5 motors and methods of use2014
Synthesis and applications of triazaborolopyridinium compounds and substituted t2014
Compounds for binding to ER alpha/beta and GPR30, methods of treating disease st2013
Compounds for binding to ER alpha/beta and GPR30, methods of treating disease st2013
Compounds for binding to ER alpha/beta and GPR30, methods of treating disease st2013